BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

ALS Therapy Development Institute 

215 First Street

Cambridge  Massachusetts    U.S.A.
Phone: 617-441-7200 Fax: 617-441-7299


SEARCH JOBS




Industry
Biotechnology






 Company News
ALS Therapy Development Institute and Anida Pharma Partner to Investigate Potential Treatments for ALS 9/10/2013 10:23:08 AM
ALS Therapy Development Institute Adds Two Board Members 5/2/2013 7:50:58 AM
ALS Therapy Development Institute Release: FDA Approves Clinical Trial of TDI-132 (Gilenyaв) in ALS Patients 2/11/2013 9:16:16 AM
ALS Therapy Development Institute and To-BBB technologies BV Collaborate on Potential Treatments for Motor Neuron Disease 1/8/2013 10:10:07 AM
ALS Therapy Development Institute and Gladstone Institute Collaborate to Discover Potential ALS Treatments 12/4/2012 9:50:38 AM
ALS Therapy Development Institute Announces Research Agreement with Biogen Idec, Inc. (Massachusetts) (BIIB) and UCB Pharma (UCBJF.PK) to Investigate the Role of CD40L in ALS 12/19/2011 10:38:14 AM
U.S. Congressman Michael Capuano to Receive "Lou Gehrig Award" from ALS Therapy Development Institute During Gala Event this November 6/7/2011 9:38:38 AM
ALS Therapy Development Institute Appoints Anil Godhwani to Board of Directors 2/4/2011 9:52:54 AM
ALS Therapy Development Institute and Oxford BioMedica PLC (OXB.L) Begin Second Phase of Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis 1/28/2010 7:57:44 AM
ALS Therapy Development Institute, the World's Largest Non-Profit Biotech, Appoints Steve Perrin, Ph.D., as Chief Executive Officer 5/4/2009 7:51:54 AM
12